LAWSON BYRON (SVP/Chief Commercial Officer) reported 1 transaction at HTG MOLECULAR DIAGNOSTICS, INC
Review the transaction codes below to understand the nature of each event.
Filed: 1/4/2022ACC: 0001209191-22-000857
Officer· SVP/Chief Commercial Officer
Since Jan 2020
-24.00
Net shares
Net seller
$130.08
Total sold
0
Open market trades
0B · 0S
1
Total transactions
24.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−24.00
Price / share
$5.42
Trade value
$130.08
% of position
0.6%
12/31/2021
4.10K→4.08K
Total
Net shares
−24.00
Net value
-$130.08
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2021 | F · Tax Withholding | −24.00 | $5.42 | $130.08 | 0.6% | 4.10K | 4.08K |
| Total | −24.00 | -$130.08 | ||||||
Derivative Transactions0
No derivative transactions reported